Zahid Kocak, Mehmet. “Comment on ‘Impact of Performance Status on Non-Small Cell Lung Cancer Patients With a PD-L1 Tumour Proportion Score ≥50% Treated With Front-Line pembrolizumab’”. Acta Oncologica, vol. 60, no. 4, Apr. 2021, pp. 564-5, doi:10.1080/0284186X.2021.1889028.